The Cooper Companies, Inc. (NASDAQ:COO) Given Consensus Recommendation of “Moderate Buy” by Analysts

The Cooper Companies, Inc. (NASDAQ:COO) has been assigned an average recommendation of “Moderate Buy” from the seventeen ratings firms that are presently covering the company, MarketBeat reports. One analyst has rated the stock with a sell recommendation, seven have issued a hold recommendation, eight have given a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $90.7857.

Several research firms have recently commented on COO. Needham & Company LLC boosted their price target on Cooper Companies from $99.00 to $101.00 and gave the stock a “buy” rating in a research report on Friday, March 6th. Wall Street Zen raised Cooper Companies from a “hold” rating to a “buy” rating in a research report on Saturday, February 28th. William Blair raised Cooper Companies to a “strong-buy” rating in a research report on Friday, January 30th. Rothschild & Co Redburn lowered Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 target price on the stock. in a research report on Wednesday, March 4th. Finally, Citigroup reduced their target price on Cooper Companies from $88.00 to $87.00 and set a “neutral” rating on the stock in a research report on Friday, March 6th.

Cooper Companies Trading Down 0.5%

Shares of NASDAQ COO opened at $62.55 on Friday. The company has a quick ratio of 0.79, a current ratio of 1.34 and a debt-to-equity ratio of 0.22. The business has a fifty day simple moving average of $66.92 and a two-hundred day simple moving average of $75.14. The firm has a market cap of $12.20 billion, a PE ratio of 30.97, a price-to-earnings-growth ratio of 1.61 and a beta of 0.89. Cooper Companies has a twelve month low of $58.89 and a twelve month high of $89.83.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, March 5th. The medical device company reported $1.10 EPS for the quarter, topping the consensus estimate of $1.03 by $0.07. The firm had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.02 billion. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The business’s revenue for the quarter was up 6.2% compared to the same quarter last year. During the same period in the previous year, the company posted $0.92 EPS. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. Analysts expect that Cooper Companies will post 4.62 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. JANA Partners Management LP purchased a new stake in Cooper Companies during the 3rd quarter valued at about $166,917,000. Alecta Tjanstepension Omsesidigt grew its stake in Cooper Companies by 15.8% during the 3rd quarter. Alecta Tjanstepension Omsesidigt now owns 1,563,000 shares of the medical device company’s stock valued at $107,112,000 after purchasing an additional 213,500 shares during the last quarter. DAVENPORT & Co LLC grew its stake in Cooper Companies by 1,359.7% during the 4th quarter. DAVENPORT & Co LLC now owns 567,203 shares of the medical device company’s stock valued at $46,642,000 after purchasing an additional 528,346 shares during the last quarter. Swiss Life Asset Management Ltd grew its stake in Cooper Companies by 63.9% during the 3rd quarter. Swiss Life Asset Management Ltd now owns 49,409 shares of the medical device company’s stock valued at $3,387,000 after purchasing an additional 19,264 shares during the last quarter. Finally, Fluent Financial LLC purchased a new stake in Cooper Companies during the 4th quarter valued at about $3,517,000. 24.39% of the stock is owned by institutional investors and hedge funds.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.